Delorbis Pharmaceuticals LTD

Delorbis Pharmaceuticals LTD was established in 1989 as a branded generic pharmaceutical company. The organization maintains a portfolio of over 100 pharmaceutical products that are EU-approved and designed to address local therapeutic requirements. Its operations span more than 35 markets across the Middle East, Africa, the Far East, and the CIS region. Through international strategic partnerships, the company has developed a substantial generic drug pipeline and pursues growth strategies combining marketing and sales initiatives with partner collaboration to identify potential products.

The company operates manufacturing facilities located in the Ergates Industrial Area in Lefkosia, Cyprus. These premises comprise two standard production units and one specialized cytotoxic unit, equipped with departments handling production, packaging, quality control, quality assurance, product development, and warehousing. Operations adhere to European Good Manufacturing Practice (EU-GMP) regulations and standards. In addition to manufacturing its own branded generic products, Delorbis Pharmaceuticals LTD offers quality control services and contract manufacturing capabilities to other pharmaceutical companies.